Dr. Tanuja Chitnis, MD

Dr. Chitnis practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Chitnis' NPI, 1376517078, was assigned on February 17, 2006. Dr. Chitnis holds Massachusetts license 160667.

Dr. Chitnis' primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Chitnis' primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Chitnis is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Chitnis to 2 more medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chitnis practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chitnis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chitnis is licensed in Massachusetts.

CMS data shows 59 Medicare services from Dr. Chitnis across 2 procedure codes in 2024, for 31 Medicare patients. Medicare paid $5,267 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Chitnis in 2024. The largest group is under 65, with 17 patients. 52% of them have high cholesterol, and 48% have high blood pressure. 39% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chitnis' median patient age at 59, with 75% women.

In 2024, Dr. Chitnis wrote 461 Medicare Part D claims for 43 patients. 77% of them were for generic drugs. CMS names the drug for 316 of them, across 17 drugs with 11 or more claims each, at $715,091 in total drug cost. In 2023, CMS named 307 claims across 19 drugs.

Dr. Chitnis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chitnis as offering telehealth.

Dmand AI links 333 papers to Dr. Chitnis, published from 2010 to 2025. 2023 was the busiest year, with 32. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Disease Progression. Dr. Chitnis has published most often in Mult Scler. Dr. Chitnis' most frequent co-authors are Lauren B. Krupp, MD, Howard Lee Weiner, MD and Soe Soe Mar, MD.

Dmand AI links Dr. Chitnis to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS and Multiple Sclerosis, Relapsing-Remitting. Genzyme, a Sanofi Company sponsors the most, 2. Open Payments lists research payments to Dr. Chitnis that name 2 trials.

CMS Open Payments shows 202 general payments to Dr. Chitnis from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Genentech, Inc. paid the most, $60,166. It also lists 33 research payments totaling $37,995 from 2017 to 2025, naming 2 clinical trials.